1. Home
  2. MNKD vs MNR Comparison

MNKD vs MNR Comparison

Compare MNKD & MNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • MNR
  • Stock Information
  • Founded
  • MNKD 1991
  • MNR 2017
  • Country
  • MNKD United States
  • MNR United States
  • Employees
  • MNKD N/A
  • MNR N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • MNR
  • Sector
  • MNKD Health Care
  • MNR
  • Exchange
  • MNKD Nasdaq
  • MNR Nasdaq
  • Market Cap
  • MNKD 1.7B
  • MNR 2.0B
  • IPO Year
  • MNKD 2004
  • MNR 2023
  • Fundamental
  • Price
  • MNKD $5.00
  • MNR $11.85
  • Analyst Decision
  • MNKD Buy
  • MNR Strong Buy
  • Analyst Count
  • MNKD 6
  • MNR 4
  • Target Price
  • MNKD $10.25
  • MNR $21.00
  • AVG Volume (30 Days)
  • MNKD 4.3M
  • MNR 391.0K
  • Earning Date
  • MNKD 11-05-2025
  • MNR 11-06-2025
  • Dividend Yield
  • MNKD N/A
  • MNR 23.18%
  • EPS Growth
  • MNKD 23.47
  • MNR N/A
  • EPS
  • MNKD 0.10
  • MNR 0.92
  • Revenue
  • MNKD $313,787,000.00
  • MNR $956,307,000.00
  • Revenue This Year
  • MNKD $14.78
  • MNR $20.17
  • Revenue Next Year
  • MNKD $19.36
  • MNR $34.33
  • P/E Ratio
  • MNKD $50.82
  • MNR $12.84
  • Revenue Growth
  • MNKD 17.43
  • MNR 9.45
  • 52 Week Low
  • MNKD $3.38
  • MNR $11.39
  • 52 Week High
  • MNKD $7.07
  • MNR $19.00
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 39.71
  • MNR 42.99
  • Support Level
  • MNKD $4.95
  • MNR $11.77
  • Resistance Level
  • MNKD $6.24
  • MNR $12.24
  • Average True Range (ATR)
  • MNKD 0.29
  • MNR 0.36
  • MACD
  • MNKD -0.08
  • MNR 0.05
  • Stochastic Oscillator
  • MNKD 4.26
  • MNR 48.46

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About MNR Mach Natural Resources LP

Mach Natural Resources LP is an independent upstream oil and gas company. The company is focused on the acquisition, development and production of oil, natural gas, and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas, and the panhandle of Texas.

Share on Social Networks: